View : 749 Download: 0
Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers
- Title
- Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers
- Authors
- Cho, Sung-Yup; Oh, Yumi; Jeong, Eui Man; Park, Sanghui; Lee, Dakeun; Wang, Xiaorui; Zeng, Qiqi; Qin, Hongyu; Hu, Fang; Gong, Hui; Liu, Xi; Zhang, Guanjun; Na, Deukchae; Lee, Jieun; Chae, Jeesoo; Suh, Yun-Suhk; Kong, Seong-Ho; Lee, Hyuk-Joon; Jong-Il Kim; Park, Hansoo; Zhang, Chengsheng; Yang, Han-Kwang; Lee, Charles
- Ewha Authors
- 박상희; Charles Lee; 이지은; 나득채
- SCOPUS Author ID
- 박상희; Charles Lee; 이지은; 나득채
- Issue Date
- 2020
- Journal Title
- EXPERIMENTAL AND MOLECULAR MEDICINE
- ISSN
- 1226-3613
2092-6413
- Citation
- EXPERIMENTAL AND MOLECULAR MEDICINE vol. 52, no. 5, pp. 854 - 864
- Publisher
- NATURE PUBLISHING GROUP
- Indexed
- SCIE; SCOPUS; KCI
- Document Type
- Article
- Abstract
- Stomach cancer: Enzyme promotes problematic inflammation An enzyme linked to harmful inflammation that promotes tumor growth could be a target for stomach cancer treatment. The expression of the enzyme transglutaminase 2 (TGM2) has been shown to increase in several types of cancer, but its precise role has been unclear. Sung-Yup Cho at Seoul National University College of Medicine, Korea and co-workers measured copy numbers and expression levels of TGM2 in gastric cancer cell lines and in tissue samples from patients undergoing gastrectomy. They found that higher levels of TGM2 were closely associated with increases in various genes that promote the recruitment and activity of tumor-associated macrophages, malfunctioning white blood cells that drive tumor-promoting inflammation. In addition, stomach cancer patients with higher expression of TGM2 had poorer prognoses, indicating the potential therapeutic value of targeting this enzyme. Tumor-promoting inflammation is a hallmark of cancer and is highly associated with tumor progression, angiogenesis, and metastasis. Tumor-associated macrophages (TAMs) are major drivers of tumor-promoting inflammation, but due to the complexity of the tumor microenvironment, the detailed regulatory mechanisms are still under investigation. Here, we investigated a novel role for transglutaminase 2 (TGM2) in the development of tumor-promoting inflammation and recruitment of TAMs to gastric cancer (GC) tissues. When estimated by array comparative genomic hybridization and droplet digital PCR, the copy numbers of the TGM2 gene were amplified in 13.6% (14/103) of GC patients and positively associated with TGM2 expression. Gene set enrichment analysis of expression microarray data for GC samples with high or low TGM2 expression showed that increased TGM2 expression was associated with tumor-promoting inflammation in GC. In addition, the expression of TGM2 was correlated with the expression of markers for macrophages, neutrophils, blood vessels, and lymphatic vessels. Overexpression of TGM2 in GC cells augmented the IL-1 beta-induced secretion of macrophage-recruiting chemokines and NF-kappa B activation. TGM2 protein levels were associated with the expression levels of the macrophage marker CD163 in human GC tissue samples. Moreover, GC patients with high expression of TGM2 had a worse prognosis than those with low expression of TGM2. These results suggest TGM2 as a novel regulator of the tumor microenvironment of GC and provide a promising target for constraining tumor-promoting inflammation.
- DOI
- 10.1038/s12276-020-0444-7
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML